Abstract:Background Hyperhomocysteinemia (HHcy) causes cardiovascular diseases via regulating inflammatory responses. We investigated whether and how the epithelial sodium channel (ENaC), a recently identified ion channel in endothelial cells, plays a role in HHcy-induced endothelial dysfunction. Methods Cell-attached patch-clamp recording in acute split-open aortic endothelial cells, western blot, confocal imaging, and wire myograph combined with pharmacological approaches were used to determine whether HHcy-mediated inflammatory signaling leads to endothelial dysfunction via stimulating ENaC. Results The data showed that 4 weeks after L-methionine diet the levels of plasma Hcy were significantly increased and the ENaC was dramatically activated in mouse aortic endothelial cells. Administration of benzamil, a specific ENaC blocker, ameliorated L-methionine diet-induced impairment of endothelium-dependent relaxation (EDR) and reversed Hcy-induced increase in ENaC activity. Pharmacological inhibition of NADPH oxidase, reactive oxygen species (ROS), cyclooxygenase-2 (COX-2)/thromboxane B2 (TXB2), or serum/glucocorticoid regulated kinase 1 (SGK1) effectively attenuated both the Hcy-induced activation of endothelial ENaC and impairment of EDR. Our in vitro data showed that both NADPH oxidase inhibitor and an ROS scavenger reversed Hcy-induced increase in COX-2 expression in human umbilical vein endothelial cells (HUVECs). Moreover, Hcy-induced increase in expression levels of SGK-1, phosphorylated-SGK-1, and phosphorylated neural precursor cell-expressed developmentally downregulated protein 4-2 (p-Nedd4-2) in HUVECs were significantly blunted by a COX-2 inhibitor. Conclusion We show that Hcy activates endothelial ENaC and subsequently impairs EDR of mouse aorta, via ROS/COX-2-dependent activation of SGK-1/Nedd4-2 signaling. Our study provides a rational that blockade of the endothelial ENaC could be potential method to prevent and/or to treat Hcy-induced cardiovascular disease.

Homocysteine ameliorates the endothelium-independent hypoxic vasoconstriction via the suppression of phosphatidylinositol 3-kinase/Akt pathway in porcine coronary arteries

Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction.

PKC/NADPH Oxidase Are Involved in the Protective Effect of Pioglitazone in High Homocysteine-Induced Paracrine Dyfunction in Endothelial Progenitor Cells.

Induction of heme oxygenase-1 ameliorates vascular dysfunction in streptozotocin-induced type 2 diabetic rats (Reprinted from Vascular Pharmacology, 61, pg 16-24)

Effects of Astragalus Membranaceus and Its Main Components on the Acute Phase Endothelial Dysfunction Induced by Homocysteine

Atorvastatin Attenuates Homocysteine-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Via Inhibiting NADPH Oxidase-Related Oxidative Stress-Triggered P38mapk Signaling

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)

Homocysteine Reduces Protein S-Nitrosylation in Endothelium

Endothelium-Independent Hypoxic Contraction is Prevented Specifically by Nitroglycerin Via Inhibition of Akt Kinase in Porcine Coronary Artery

Hydrogen Sulphide Reduces Hyperhomocysteinaemia-Induced Endothelial ER Stress by Sulfhydrating Protein Disulphide Isomerase to Attenuate Atherosclerosis.

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation

Possible Involvement of NADPH Oxidase and JNK in Homocysteine-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells.

Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway

Effect of hyperhomocysteinemia on ischemic disease in rats

Homocysteine Impairs Coronary Artery Endothelial Function by Uncoupling Endothelial Nitric Oxide Synthase in Patients with Hyperhomocysteinemia

Atorvastatin Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells.

Phytoestrogen Α-Zearalanol Attenuates Homocysteine-Induced Apoptosis in Human Umbilical Vein Endothelial Cells

Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.

Naringenin ameliorates homocysteine induced endothelial damage via the AMPKα/Sirt1 pathway

Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP

Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation.